Last reviewed · How we verify
Flamboyant 125/12
Flamboyant 125/12 is a fixed-dose combination of a calcium channel blocker and a beta blocker.
Flamboyant 125/12 is a fixed-dose combination of a calcium channel blocker and a beta blocker. Used for Hypertension.
At a glance
| Generic name | Flamboyant 125/12 |
|---|---|
| Sponsor | EMS |
| Drug class | Calcium channel blocker/beta blocker combination |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action is not well-documented, but it is believed to work by reducing blood pressure through a combination of vasodilation and decreased cardiac output.
Approved indications
- Hypertension
Common side effects
- Edema
- Dizziness
- Fatigue
Key clinical trials
- Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |